Beyond the Heel Prick
Could whole genome sequencing redefine newborn care?
-
By
-
Sukhvinder Nicklen
-
April 28, 2026
-
Clinical Scorecard: Beyond the Heel Prick
At a Glance
| Category | Detail |
|---|
| Condition | Spinal Muscular Atrophy and other rare diseases |
| Key Mechanisms | Whole genome sequencing (WGS) for early diagnosis and risk assessment |
| Target Population | Newborns |
| Care Setting | Healthcare systems, particularly in the UK |
Key Highlights
- Scotland has added spinal muscular atrophy to its newborn screening program.
- Advances in sequencing technology enable comprehensive genomic approaches.
- Public support for genetic testing is high, with 90% of people in England willing to undergo testing.
- WGS can reduce diagnostic odyssey and improve outcomes in rare and common conditions.
- Integration of genomic data into healthcare systems is crucial for effective use.
Guideline-Based Recommendations
Diagnosis
- Implement whole genome sequencing for newborns to facilitate early diagnosis.
Management
- Adopt risk-informed screening and care pathways based on genomic data.
Monitoring & Follow-up
- Utilize genomic health records as a lifelong resource for ongoing care.
Risks
- Consider genetic variations that may affect medication efficacy and adverse reactions.
Patient & Prescribing Data
Adults receiving medications influenced by genetic variations.
Tailoring drugs and dosages to individual genomes can reduce adverse drug reactions.
Clinical Best Practices
- Generate reliable genomic health records for lifelong use.
- Build a connected data infrastructure linking genomic data with electronic health records.
- Empower individuals to access their genomic records for informed decision-making.
- Move from binary screening to disease stratification for tailored clinical decisions.
References
